• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ZTS:US

29.3900 USD 0.5000 1.67%

As of 20:04:06 ET on 04/23/2014.

Snapshot for Zoetis Inc (ZTS)

Open: 29.7500 Day's Range: 29.3000 - 29.8900 Volume: 3,803,292
Previous Close: 29.8900 52wk Range: 28.1350 - 34.7400 1-Yr Rtn: -2.96%

Stock Chart for ZTS

No chart data available.
  • ZTS:US 29.3900
  • 1D
  • 1M
  • 1Y
29.8900
Interactive ZTS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ZTS

Current P/E Ratio (ttm) 21.4477
Estimated P/E(12/2014) 19.1841
Relative P/E vs. SPX 1.2500
Earnings Per Share (USD) (ttm) 1.3703
Est. EPS (USD) (12/2014) 1.5320
Est. PEG Ratio 1.6514
Market Cap (M USD) 14,716.44
Shares Outstanding (M) 500.73
30 Day Average Volume 4,516,801
Price/Book (mrq) 15.6330
Price/Sale (ttm) 3.2219
Dividend Indicated Gross Yield 0.98%
Cash Dividend (USD) 0.0720
Dividend Ex-Date 04/24/2014
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ZTS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ZTS

Zoetis Inc discovers, develops, manufactures and commercializes animal health medicines and vaccines, with a focus on both livestock and companion animals. The Companies products are sold in North America, Europe, Africa, Asia, Australia and Latin America.

Juan Ramon AlaixChief Executive OfficerGlenn DavidActing CFO/Senior VP:Finance Ops
Kristin C PeckExec VP/Group PresidentRoxanne LaganoExec VP/Chief HR Officer
More Company Profile & Key Executives for ZTS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil